Resilience System

Remdesivir cut death risk by up to 25% in adults with COVID and no added oxygen

Primary tabs

posted by mike kraft on Wed, 2024-04-17 17:54

Remdesivir cut death risk by up to 25% in adults with COVID and no added oxygen

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen The antiviral drug remdesivir cut death rates 17% to 25% in adults hospitalized for COVID-19 who didn't require supplemental oxygen at admission, suggests a large US study published yesterday in Open Forum Infectious Diseases. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Language

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Recent Content

NIH director says Trump's anti-DEI orders misunderstood and agency still supports research that advances health of minorities.

Housing: 60,000 Americans to lose their rental assistance and risk eviction unless Congress renews funds

Trump administration cuts lab dealing with sexually transmitted diseases as syphillis cases rise.

NIH considering halting all new research grants to half a dozen top universities.

Proposed Medicaid cuts risk making the Black maternal health crises worse.

Who's online

There are currently 0 users online.